Effects of radiation on the epidermal growth factor receptor pathway in the heart

International Journal of Radiation Biology

Volumn 89, Issue 7, 2013, Pages 539-547

  Sridharan, Vijayalakshmi ^a   Sharma, Sunil K ^b   Moros, Eduardo G ^c   Corry, Peter M ^b   Tripathi, Preeti ^a   Lieblong, Benjamin J ^a   Guha, Chandan ^d   Hauer Jensen, Martin ^a,e   Boerma, Marjan ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d MONTEFIORE MEDICAL CENTER   (United States)

^e CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Epidermal growth factor receptor pathway; Neuregulin 1; Radiation induced heart disease; Tocotrienols

Indexed keywords

ALPHA TOCOTRIENOL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; HEAT SHOCK PROTEIN 90; MESSENGER RNA; NEU DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CONTROLLED STUDY; DOWN REGULATION; ERYTHROLEUKEMIA; GENE EXPRESSION; HEART; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RADIATION DOSE; RADIATION RESPONSE; RAT; STATISTICAL SIGNIFICANCE; UPREGULATION; VIRUS ONCOGENE;

ANIMALS; HEART; MALE; MYOCARDIUM; RADIATION TOLERANCE; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TOCOTRIENOLS;

RATTUS;

EID: 84879744076     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2013.782110     Document Type: Article

References (70)

1. Adams MJ, Hardenbergh PH, Constine LS, Lipshultz SE. 2003. Radiation-associated cardiovascular disease. Critical Reviews in Oncology Hematology 45 : 55-75. (Pubitemid 35449788)
2. Aggarwal BB, Sundaram C, Prasad S, Kannappan R. 2010. Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases. Biochemical Pharmacology 80: 1613-1631.
3. Ammendola R, Mesuraca M, Russo T, Cimino F. 1994. The DNAbinding efficiency of Sp1 is aff ected by redox changes. European Journal of Biochemistry 225 : 483-489. (Pubitemid 24306275)
4. Berbee M, Fu Q, Boerma M, Wang J, Kumar KS, Hauer-Jensen M. 2009. gamma-Tocotrienol ameliorates intestinal radiation injury and reduces vascular oxidative stress after total-body irradiation by an HMG-CoA reductase-dependent mechanism. Radiation Research 171 : 596-605.
5. Berbee M, Hauer-Jensen M. 2012. Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: What is emerging from the laboratory? Current Opinion in Support and Palliative Care 6: 54-59.
6. Bersell K, Arab S, Haring B, Kuhn B. 2009. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell 138 : 257-270.
7. Bublil EM, Yarden Y. 2007. The EGF receptor family: Spearheading a merger of signaling and therapeutics. Current Opinion in Cell Biology 19 : 124-134. (Pubitemid 46386405)
8. Calabrese V, Scapagnini G, Ravagna A, Colombrita C, Spadaro F, Butterfield DA, Giuffrida Stella AM. 2004. Increased expression of heat shock proteins in rat brain during aging: Relationship with mitochondrial function and glutathione redox state. Mechanisms of Ageing and Development 125: 325-335. (Pubitemid 38438512)
9. Camprecios G, Lorita J, Pardina E, Peinado-Onsurbe J, Soley M, Ramirez I. 2011. Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart. Journal of Cellular Physiology 226: 450-455.
10. Cho HS, Mason K, Ramyar KX, Stanley AM, Gabelli SB, Denney DW Jr, Leahy DJ. 2003. Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab. Nature 421: 756-760. (Pubitemid 36227628)
11. Cote GM, Miller TA, Lebrasseur NK, Kuramochi Y, Sawyer DB. 2005. Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro. Experimental Cell Research 311: 135-146. (Pubitemid 41527182)
12. Crone SA, Zhao YY, Fan L, Gu Y, Minamisawa S, Liu Y, Peterson KL, Chen J, Kahn R, Condorelli G, Ross J Jr, Chien KR, Lee KF. 2002. ErbB2 is essential in the prevention of dilated cardiomyopathy. Nature Medicine 8 : 459-465. (Pubitemid 34546747)
13. Devic S, Seuntjens J, Sham E, Podgorsak EB, Schmidtlein CR, Kirov AS, Soares CG. 2005. Precise radiochromic film dosimetry using a flatbed document scanner. Medical Physics 32: 2245-2253. (Pubitemid 41023182)
14. Dienstmann R, Markman B, Tabernero J. 2012. Application of monoclonal antibodies as cancer therapy in solid tumors. Current Clinical Pharmacology 7: 137-145.
15. Felemovicius I, Bonsack ME, Baptista ML, Delaney JP. 1995. Intestinal radioprotection by vitamin E (alpha-tocopherol). Annals of Surgery 222 : 504-508.
16. Ferreira-Machado SC, Rocha NN, Mencalha AL, De Melo LD, Salata C, Ribeiro AF, Torres TS, Mandarim-De-Lacerda CA, Canary PC, Peregrino AA, Magalhaes LA, Cabral-Neto JB, Dealmeida CE. 2010. Up-regulation of angiotensin-converting enzyme and angiotensin II type 1 receptor in irradiated rats. International Journal of Radiation Biology 86: 880-887.
17. Franken NA, van der Laarse A, Bosker FJ, Reynart IW, Van Ravels FJ, Strootman E, Wondergem J. 1992. Time dependent changes in myocardial norepinephrine concentration and adrenergic receptor density following X-irradiation of the rat heart. International Journal of Radiation Oncology Biology Physics 24: 721-727.
18. Frensing T, Kaltschmidt C, Schmitt-John T. 2008. Characterization of a neuregulin-1 gene promoter: Positive regulation of type I isoforms by NF-kappaB. Biochimica et Biophysica Acta 1779: 139-144.
19. Fuller SJ, Sivarajah K, Sugden PH. 2008. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium. Journal of Molecular and Cellular Cardiology 44 : 831-854.
20. Gabrielson K, Bedja D, Pin S, Tsao A, Gama L, Yuan B, Muratore N. 2007. Heat shock protein 90 and ErbB2 in the cardiac response to doxorubicin injury. Cancer Research 67: 1436-1441. (Pubitemid 46383368)
21. Garcia-Rivello H, Taranda J, Said M, Cabeza-Meckert P, Vila-Petroff M, Scaglione J, Ghio S, Chen J, Lai C, Laguens RP, Lloyd KC, Hertig CM. 2005. Dilated cardiomyopathy in Erb-b4-deficient ventricular muscle. American Journal of Physiolology Heart and Circulatory Physiology 289: H1153-H1160. (Pubitemid 41208959)
22. Garrett TP, McKern NM, Lou M, Elleman TC, Adams TE, Lovrecz GO, Kofler M, Jorissen RN, Nice EC, Burgess AW, Ward CW. 2003. The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors. Molecular Cell 11 : 495-505. (Pubitemid 36293841)
23. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R, Lemke G. 1995. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378 : 390-394.
24. Gatta G, Zigon G, Capocaccia R, Coebergh JW, Desandes E, Kaatsch P, Pastore G, Peris-Bonet R, Stiller CA. 2009. Survival of European children and young adults with cancer diagnosed 1995-2002. European Journal of Cancer 45 : 992-1005.
25. Heidenreich PA, Hancock SL, Vagelos RH, Lee BK, Schnittger I. 2005. Diastolic dysfunction after mediastinal irradiation. American Heart Journal 150 : 977-982. (Pubitemid 41607777)
26. Heidenreich PA, Kapoor JR. 2009. Radiation induced heart disease: Systemic disorders in heart disease. Heart 95: 252-258.
27. Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE, Yarden Y. 1996. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: Implications for breast cancer. EMBO Journal 15 : 254-264. (Pubitemid 26029205)
28. Kavanagh BD, Lin PS, Chen P, Schmidt-Ullrich RK. 1995. Radiationinduced enhanced proliferation of human squamous cancer cells in vitro: A release from inhibition by epidermal growth factor. Clinical Cancer Research 1: 1557-1562. (Pubitemid 26028090)
29. Knowlton AA, Kapadia S, Torre-Amione G, Durand JB, Bies R, Young J, Mann DL. 1998. Diff erential expression of heat shock proteins in normal and failing human hearts. Journal of Molecular and Cellular Cardiology 30 : 811-818. (Pubitemid 28190725)
30. Kulkarni S, Ghosh SP, Satyamitra M, Mog S, Hieber K, Romanyukha L, Gambles K, Toles R, Kao TC, Hauer-Jensen M, Kumar KS. 2010. Gammatocotrienol protects hematopoietic stem and progenitor cells in mice after total-body irradiation. Radiation Research 173: 738-747.
31. Kulkarni SS, Cary LH, Gambles K, Hauer-Jensen M, Kumar KS, Ghosh SP. 2012. Gamma-tocotrienol, a radiation prophylaxis agent, induces high levels of granulocyte colony-stimulating factor. International Immunopharmacology 14 : 495-503.
32. Kuramochi Y, Cote GM, Guo X, Lebrasseur NK, Cui L, Liao R, Sawyer DB. 2004. Cardiac endothelial cells regulate reactive oxygen speciesinduced cardiomyocyte apoptosis through neuregulin-1beta/erbB4 signaling. J ournal of Biological Chemistry 279: 51141-51147. (Pubitemid 40017856)
33. Kuramochi Y, Guo X, Sawyer DB. 2006. Neuregulin activates erbB2-dependent src/FAK signaling and cytoskeletal remodeling in isolated adult rat cardiac myocytes. Journal of Molecular and Cellular Cardiology 41 : 228-235. (Pubitemid 44080212)
34. Lammering G, Hewit Th, Valerie K, Lin PS, Contessa JN, Schmidt-Ullrich RK. 2003. Anti-erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours. International Journal of Radiation Biology 79: 561-568. (Pubitemid 37311061)
35. Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C. 1995. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378 : 394-398.
36. Lemmens K, Segers VF, Demolder M, De Keulenaer GW. 2006. Role of neuregulin-1/ErbB2 signaling in endothelium-cardiomyocyte crosstalk. Journal of Biological Chemistry 281: 19469-19477. (Pubitemid 44035451)
37. Li XH, Fu D, Latif NH, Mullaney CP, Ney PH, Mog SR, Whitnall MH, Srinivasan V, Xiao M. 2010. Delta-tocotrienol protects mouse and human hematopoietic progenitors from gamma-irradiation through extracellular signal-regulated kinase/mammalian target of rapamycin signaling. Haematologica 95: 1996-2004.
38. Li YQ, Ballinger JR, Nordal RA, Su ZF, Wong CS. 2001. Hypoxia in radiation-induced blood-spinal cord barrier breakdown. Cancer Research 61: 3348-3354. (Pubitemid 32695024)
39. Linssen MC, van Nieuwenhoven FA, Duijvestijn AM, Glatz JF, van D, Vusse GJ. 1993. Continuous endothelial cells from adult rat heart. In Vitro Cellular and Developmental Biology-Animal 29A: 611-613. (Pubitemid 23286965)
40. Ma CM, Coffey CW, DeWerd LA, Liu C, Nath R, Seltzer SM, Seuntjens JP. 2001. AAPM protocol for 40-300 kV X-ray beam dosimetry in radiotherapy and radiobiology. Medical Physics 28: 868-893. (Pubitemid 32574672)
41. Marks LB, Yu X, Prosnitz RG, Zhou SM, Hardenbergh PH, Blazing M, Hollis D, Lind P, Tisch A, Wong TZ, Borges-Neto S. 2005. The incidence and functional consequences of RT-associated cardiac perfusion defects. International Journal of Radiation Oncolology Biololgy and Physics 63: 214-223. (Pubitemid 41583561)
42. Meijer IM, van Leeuwen JE. 2011. ERBB2 is a target for USP8-mediated deubiquitination. Cellular Signaling 23: 458-467.
43. Meyer D, Birchmeier C. 1995. Multiple essential functions of neuregulin in development. Nature 378: 386-390.
44. Munk M, Memon AA, Goetze JP, Nielsen LB, Nexo E, Sorensen BS. 2012. Hypoxia changes the expression of the epidermal growth factor (EGF) system in human hearts and cultured cardiomyocytes. PLoS One 7 : e40243
45. Naito Y, Shimozawa M, Kuroda M, Nakabe N, Manabe H, Katada K, Kokura S, Ichikawa H, Yoshida N, Noguchi N, Yoshikawa T. 2005. Tocotrienols reduce 25-hydroxycholesterol-induced monocyteendothelial cell interaction by inhibiting the surface expression of adhesion molecules. Atherosclerosis 180 : 19-25.
46. Ozcelik C, Erdmann B, Pilz B, Wettschureck N, Britsch S, Hubner N, Chien KR, Birchmeier C, Garratt AN. 2002. Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy. Proceedings of the National Academy of Sciences 99 : 8880-8885. (Pubitemid 34693652)
47. Pazo Cid RA, Anton A. 2013. Advanced HER2-positive gastric cancer: Current and future targeted therapies. Critical Reviews in Oncology Hematology 85 : 350-362.
48. Pearce BC, Parker RA, Deason ME, Qureshi AA, Wright JJ. 1992. Hypocholesterolemic activity of synthetic and natural tocotrienols. Journal of Medicinal Chemistry 35 : 3595-3606.
49. Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ. 2008. Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. Journal of Clinical Oncology 26 : 1231-1238.
50. Phillips BE, Tubbs RR, Rice TW, Rybicki LA, Plesec T, Rodriguez CP, Videtic GM, Saxton JP, Ives DI, Adelstein DJ. 2012. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction. Diseases of the Esophagus, in press.
51. Sanchez-Soria P, Camenisch TD. 2010. ErbB signaling in cardiac development and disease. Seminars in Cell and Developmental Biology 21 : 929-935.
52. Sang J, Yang K, Sun Y, Han Y, Cang H, Chen Y, Shi G, Wang K, Zhou J, Wang X, Yi J. 2011. SUMO2 and SUMO3 transcription is diff erentially regulated by oxidative stress in an Sp1-dependent manner. Biochemical Journal 435: 489-498.
53. Schmidt-Ullrich RK, Contessa JN, Lammering G, Amorino G, Lin PS. 2003. ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene 22 : 5855-5865. (Pubitemid 37176706)
54. Schmidt-Ullrich RK, Valerie KC, Chan W, McWilliams D. 1994. Altered expression of epidermal growth factor receptor and estroge receptor in MCF-7 cells after single and repeated radiation exposures. International Journal of Radiation, Oncology, Biology, Physics 29 : 813-819. (Pubitemid 24241322)
55. Schultz-Hector S. 1992. Radiation-induced heart disease: Review of experimental data on dose response and pathogenesis. International Journal of Radiation Biology 61 : 149-160.
56. Schultz-Hector S, Bohm M, Blochel A, Dominiak P, Erdmann E, Muller-Schauenburg W, Weber A. 1992. Radiation-induced heart disease: Morphology, changes in catecholamine synthesis and content, beta-adrenoceptor density, and hemodynamic function in an experimental model. Radiation Research 129: 281-289.
57. Seidman A, Hudis C, Pierri MK, Shak S, Paton V, Ashby M, Murphy M, Stewart SJ, Keefe D. 2002. Cardiac dysfunction in the trastuzumab clinical trials experience. Journal of Clinical Oncology 20 : 1215-1221. (Pubitemid 34177427)
58. Sharma S, Moros EG, Griffin RJ, Webber JS, Jia D, Corry PM. 2008. Demonstration of precise millimeter beam positioning of a conformal radiation therapy system for laboratory animal research. Radiation Research Society 54th Annual Scientific Meeting Abstrac t.
59. Sharma S, Moros EG, Boerma M, Sridharan V, Han EY, Clarkson R, Hauer-Jensen M, Corry PM. 2013. A novel technique for imageguided local heart irradiation in the rat. Technology in Cancer Research and Treatment : In press.
60. Shin-Kang S, Ramsauer VP, Lightner J, Chakraborty K, Stone W, Campbell S, Reddy SA, Krishnan K. 2011. Tocotrienols inhibit AKT and ERK activation and suppress pancreatic cancer cell proliferation by suppressing the ErbB2 pathway. Free Radical Biology and Medicine 51 : 1164-1174.
61. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182. (Pubitemid 17231334)
62. Sridharan V, Tripathi P, Sharma SK, Moros EG, Corry P, Lieblong BJ, Kaschina E, Unger T, Thoene-Reineke C, Hauer-Jensen M, Boerma M. 2012. Cardiac inflammation after local irradiation is influenced by the kallikrein-kinin system. Cancer Research 72: 4984-4992.
63. Tan-Chiu E, Yothers G, Romond E, Geyer CE Jr, Ewer M, Keefe D, Shannon RP, Swain SM, Brown A, Fehrenbacher L, Vogel VG, Seay TE, Rastogi P, Mamounas EP, Wolmark N, Bryant J. 2005. Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant therapy in node-positive, human epidermal growth factor receptor 2-overexpressing breast cancer: NSABP B-31. Journal of Clinical Oncology 23 : 7811-7819. (Pubitemid 46657378)
64. Tanonaka K, Yoshida H, Toga W, Furuhama K, Takeo S. 2001. Myocardial heat shock proteins during the development of heart failure. Biochemical and Biophysical Research Communications 283 : 520-525. (Pubitemid 32924722)
65. Theriault A, Chao JT, Wang Q, Gapor A, Adeli K. 1999. Tocotrienol: A review of its therapeutic potential. Clinical Biochemistry 32 : 309-319. (Pubitemid 29416720)
66. Tureaud J, Sarkar FH, Fligiel SE, Kulkarni S, Jaszewski R, Reddy K, Yu Y, Majumdar AP. 1997. Increased expression of EGFR in gastric mucosa of aged rats. American Journal of Physiology 273: G389-398.
67. Verdecchia A, Guzzinati S, Francisci S, De AR, Bray F, Allemani C, Tavilla A, Santaquilani M, Sant M. 2009. Survival trends in European cancer patients diagnosed from 1988 to 1999. European Journal of Cancer 45 : 1042-1066.
68. Vujaskovic Z, Anscher MS, Feng QF, Rabbani ZN, Amin K, Samulski TS, Dewhirst MW, Haroon ZA. 2001. Radiation-induced hypoxia may perpetuate late normal tissue injury. International Journal of Radiation, Oncology, Biology and Physics 50: 851-855. (Pubitemid 32594826)
69. Wu R, Zeng Y. 2009. Does angiotensin II-aldosterone have a role in radiation-induced heart disease? Medical Hypotheses 72 : 263-266.
70. Wu X, Bishopric NH, Discher DJ, Murphy BJ, Webster KA. 1996. Physical and functional sensitivity of zinc finger transcription factors to redox change. Molecular and Cellular Biology 16 : 1035-1046. (Pubitemid 26061675)